Home

laut Nicht gefallen Slowenien teva buffet Verengt Initiative Ladenbesitzer

Warren Buffett boosts bet on ailing drugmaker Teva | The Times of Israel
Warren Buffett boosts bet on ailing drugmaker Teva | The Times of Israel

Berkshire Hathaway exits Teva at a loss - Globes
Berkshire Hathaway exits Teva at a loss - Globes

Berkshire (BRK/A) Takes Activision Blizzard (ATVI) Stake, Exits Teva (TEVA)  - Bloomberg
Berkshire (BRK/A) Takes Activision Blizzard (ATVI) Stake, Exits Teva (TEVA) - Bloomberg

5 "Buffett Stocks" Buffett Didn't Actually Buy | The Motley Fool
5 "Buffett Stocks" Buffett Didn't Actually Buy | The Motley Fool

5 "Buffett Stocks" Buffett Didn't Actually Buy | The Motley Fool
5 "Buffett Stocks" Buffett Didn't Actually Buy | The Motley Fool

6 Reasons Buffett Bought Into Teva Pharmaceutical, As Told by a Teva  Shareholder | The Motley Fool
6 Reasons Buffett Bought Into Teva Pharmaceutical, As Told by a Teva Shareholder | The Motley Fool

5 Warren Buffett Stocks To Buy For Under $25
5 Warren Buffett Stocks To Buy For Under $25

These 4 Stocks Have Cost Warren Buffett More Than $6 Billion in 2019 | The  Motley Fool
These 4 Stocks Have Cost Warren Buffett More Than $6 Billion in 2019 | The Motley Fool

Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical  Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
Berkshire Hathaway Inc closes position in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io

3 Stocks Warren Buffett Is Losing Money On Right Now | The Motley Fool
3 Stocks Warren Buffett Is Losing Money On Right Now | The Motley Fool

Buffett still losing heavily on Teva investment - Globes
Buffett still losing heavily on Teva investment - Globes

Warren Buffett boosts bet on ailing drugmaker Teva | The Times of Israel
Warren Buffett boosts bet on ailing drugmaker Teva | The Times of Israel

Warren Buffett Berkshire Hathaway buys more Apple, Teva; sells Wells Fargo
Warren Buffett Berkshire Hathaway buys more Apple, Teva; sells Wells Fargo

Berkshire Hathaway exits Teva at a loss - Globes
Berkshire Hathaway exits Teva at a loss - Globes

Warren Buffett buys $60 million worth of Teva in the dip - Business -  Haaretz.com
Warren Buffett buys $60 million worth of Teva in the dip - Business - Haaretz.com

Why in the World Does Warren Buffett Like Teva Pharmaceutical? | The Motley  Fool
Why in the World Does Warren Buffett Like Teva Pharmaceutical? | The Motley Fool

3 Stocks Warren Buffett Is Losing Money On Right Now | The Motley Fool
3 Stocks Warren Buffett Is Losing Money On Right Now | The Motley Fool

Warren Buffett loses nearly $300m on Teva - Globes
Warren Buffett loses nearly $300m on Teva - Globes

Warren Buffett buys $60 million worth of Teva in the dip - Business -  Haaretz.com
Warren Buffett buys $60 million worth of Teva in the dip - Business - Haaretz.com

Billionaire Buffett has probably taken $213 million loss on his Teva stock  - Business - Haaretz.com
Billionaire Buffett has probably taken $213 million loss on his Teva stock - Business - Haaretz.com

Warren Buffett buys Teva shares, cuts Phillips 66 stake - CBS News
Warren Buffett buys Teva shares, cuts Phillips 66 stake - CBS News

4 Warren Buffett Stocks He Should Sell: KO, WFC, AXP, TEVA | InvestorPlace
4 Warren Buffett Stocks He Should Sell: KO, WFC, AXP, TEVA | InvestorPlace

These 4 Stocks Have Cost Warren Buffett More Than $6 Billion in 2019 | The  Motley Fool
These 4 Stocks Have Cost Warren Buffett More Than $6 Billion in 2019 | The Motley Fool

These 4 Stocks Have Cost Warren Buffett More Than $6 Billion in 2019 | The  Motley Fool
These 4 Stocks Have Cost Warren Buffett More Than $6 Billion in 2019 | The Motley Fool

Buffett Owns Teva Pharmaceutical Stock, But Should You? | InvestorPlace
Buffett Owns Teva Pharmaceutical Stock, But Should You? | InvestorPlace

Warren Buffett recoups some Teva losses - Globes
Warren Buffett recoups some Teva losses - Globes

Buffett Owns Teva Pharmaceutical Stock, But Should You? | InvestorPlace
Buffett Owns Teva Pharmaceutical Stock, But Should You? | InvestorPlace